HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Recombinant vaccinia viruses expressing GP46/M-2 protect against Leishmania infection.

Abstract
Leishmania is a genus of parasitic protozoa capable of causing a spectrum of human diseases. The GP46/M-2 membrane glycoprotein has been demonstrated in a murine model system to elicit a protective immune response against infection with Leishmania amazonensis; in highly susceptible BALB/c mice, immunization leads to significant protection against infection. In the present study, for induction of long-term immunological effects, two recombinant vaccinia viruses, derived from the wild type and attenuated variant 48-7 and expressing the GP46/M-2 protein, were constructed; to ensure safety, we used the attenuated vaccinia virus mutant (48-7) as a live vector. Susceptible BALB/c mice immunized with either GP46/M-2-recombinant vaccinia virus were significantly protected against infection with L. amazonensis; 45 to 76% of the animals were completely protected (sterile) against a challenge inoculum of 10(3) infective organisms. The protectively immunized animals demonstrated T- and B-cell-dependent immunological responses; both lymphokine responses as well as antibody responses and long-term memory are indicative of T-cell activation. This first report of the use of a recombinant vaccinia virus to induce protection against a Leishmania infection indicates that recombinant vaccinia viruses should be of value in the design of a safe and effective vaccine against this parasitic disease.
AuthorsD McMahon-Pratt, D Rodriguez, J R Rodriguez, Y Zhang, K Manson, C Bergman, L Rivas, J F Rodriguez, K L Lohman, N H Ruddle
JournalInfection and immunity (Infect Immun) Vol. 61 Issue 8 Pg. 3351-9 (Aug 1993) ISSN: 0019-9567 [Print] United States
PMID8335366 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Membrane Glycoproteins
  • Protozoan Proteins
  • Protozoan Vaccines
  • Vaccines, Synthetic
  • surface glycoprotein GP46-M-2, Leishmania
Topics
  • Animals
  • Female
  • Leishmania mexicana (immunology)
  • Leishmaniasis, Cutaneous (prevention & control)
  • Membrane Glycoproteins (immunology)
  • Mice
  • Mice, Inbred BALB C
  • Protozoan Proteins (immunology)
  • Protozoan Vaccines (immunology)
  • Vaccination
  • Vaccines, Synthetic (immunology)
  • Vaccinia virus (genetics, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: